Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

True Leaf Medicine International Announces $3 million Non-Brokered Private Placement - Video Available on Investmentpitch.com

C.MJ

Vancouver, British Columbia--(Newsfile Corp. - May 4, 2017) - True Leaf Medicine International, (CSE: MJ) (FSE: TLA) has announced a non-brokered private placement. The company plans to raise up to $3 million through an offering of up to 10 million units priced at $0.30 per unit, with each unit consisting of one share and one warrant, with each warrant exercisable at $0.45 for a period of 24 months.

InvestmentPitch.com has produced a "video" which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "True Leaf" in the search box. The video is also available on YouTube.



Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_jv42014s/True-Leaf-Medicine-CSE-MJ-announced-a-Non-Brokered-Private-Placement

True Leaf Medicine International Ltd., through its wholly-owned subsidiary 'True Leaf Pet', has entered the $104.9 billion global pet care industry with a line of hemp-focused pet chews and supplements marketed through natural pet health and veterinary channels in Canada, the United States and Europe.

The Company has also filed an application under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR) to become a Canadian licensed producer through its 'True Leaf Medicine' subsidiary. It has passed through the security screening process of Health Canada's review and is currently in the final review stage before the 'pre-licensing inspection' approval.

The shares are trading at $0.33 and with 60.4 million shares outstanding, the company is capitalized at $19.9 million.

For more information, please visit the company's website www.trueleaf.com, contact Kevin Bottomley, Director, at 778-389-9933 or email kevin@trueleaf.com.

Investor relations is handled by Paul Sullivan of Break Through Communications, who can be reached at 604-685-4742 or by email p.sullivan@breakthtoughpr.com.

About InvestmentPitch Media

Investmentpitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today